New Onegevity Study to Explore PCOS in Women

PCOS is the most common endocrine disorder in women of reproductive age – seen in upward of 13 percent of women. Learn exactly what PCOS is, possible causes, and about how Thorne’s sister company, Onegevity, is conducting a new study to take a deep scientific look at PCOS.

Recruitment for study is for women with a current or past PCOS diagnosis. The calls for participants will close 10/31/2021.

If you are interested and eligible, then please contact the study coordinator at StudyCoordinator@onegevity.com to learn more. The study has been approved by the University of Maryland Institutional Review Board (HP-00089723).

During this episode you’ll learn about:

Special guest Dr. Amanda Frick [1:36]
Polycystic Ovary Syndrome (PCOS) [3:02]
- Several components involved [3:45]
- Symptoms [4:00]
PCOS statistics [4:19]
Diagnosis [5:00]
PCOS red flags [6:15]
Testing for PCOS [7:54]
Misconceptions [8:00]
- Other causes of cysts [8:49]
Onegevity’s focus [11:32]
Is PCOS increasing in our society? [13:45]
- Possible reasons [14:30]
The role of genes [15:58]
Body weight [16:56]
Other components of PCOS [17:55]
Supplements and PCOS [20:00]
- PCOS treatments [20:52]
Questions from the community [22:24]
- Best supplements for PCOS [22:46]
- Is vitamin C bad for PCOS [28:18]
- Inositol PCOS [28:58]
- What supplements to take on oral contraceptives [31:19]
- Why is Thorne interested in PCOS and what is Onegevity’s study [33:42]
  - Grant from National Institutes of Health [35:22]
  - Who can participate [36:52]
  - How to sign up [37:40]
  - Benefits of joining the study [38:32]

Resources to topics mentioned in this episode:

Subscribe To More Content

Make sure to never miss an episode by subscribing to the show on your podcast app. You can also learn more about what we talked about by visiting Thorne.com and checking out the latest news, videos, and stories on Thorne’s Take 5 Daily blog.

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

2356 232